MyAverix Finance
SHG · Healthcare
Hunan Fangsheng Pharm Co Ltd (603998)
Drug Manufacturers - Specialty & Generic
Hunan Fangsheng Pharm Co Ltd (603998) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $4.87B, P/E ratio is 16.55, net margin is 17.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603998
Hunan Fangsheng Pharm Co Ltd (603998) — FAQ
What is Hunan Fangsheng Pharm Co Ltd's market cap?
Hunan Fangsheng Pharm Co Ltd (603998) has a reported market cap of $4.87B (data as of 2026-03-29).
What is 603998's P/E ratio?
The price-to-earnings (P/E) ratio for Hunan Fangsheng Pharm Co Ltd (603998) is 16.55 (data as of 2026-03-29).
Does Hunan Fangsheng Pharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hunan Fangsheng Pharm Co Ltd (603998). Check the MyAverix Finance app for the latest dividend data.
What sector is Hunan Fangsheng Pharm Co Ltd in?
Hunan Fangsheng Pharm Co Ltd (603998) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603998 listed on?
603998 is listed on SHG.
What is Hunan Fangsheng Pharm Co Ltd's net margin?
Hunan Fangsheng Pharm Co Ltd (603998) reports a net margin of 17.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.